Skip to content

Finished goods at other companies

Solventum logo
SolventumSOLV
$643M+32.9%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
Medtronic logo
MedtronicMDT
STERIS logo
STERISSTE
Medline, Inc.
 logo
Medline, Inc. MDLN
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's finished goods?
Baxter International (BAX) reported finished goods of $1.36B in Q1 2026.
How has Baxter International's finished goods changed year-over-year?
Baxter International's finished goods increased by 3.7% year-over-year, from $1.31B to $1.36B.
What is the long-term trend for Baxter International's finished goods?
Over 5 years (2020 to 2025), Baxter International's finished goods has grown at a 1.0% compound annual growth rate (CAGR), from $1.26B to $1.33B.